Current Edition

Globalisation and the Importance of End-to-end Translation Management

Most manufacturers are now global in their outlook as it has become easier than ever for pharmaceutical and medical device companies to market their products all over the world. But global and local regulatory requirements can be complex and varied. Adhering to these is a significant task when registration requires translation of dossier content for each local authority. AMPLEXOR Life Sciences’ Nancy Pollini maps out her vision for what an end-to-end translation programme look like for an international life sciences firm in 2018.